Nat. Rev. Cardiol. doi: /nrcardio

Slides:



Advertisements
Similar presentations
Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Advertisements

Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Pathogenesis of Acute Coronary Syndromes Nathan Wong
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
PBL CV 2 Pathophysiology of coronary artery disease.
Low Density Lipoprotein (LDL) LDL derived from VLDL as TAG in VLDL (and IDL) removed by lipoprotein lipase  LDL major cholesterol-carrying lipoprotein.
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Lipoprotein Structures, Function and Metabolism (4)
Atherosclerosis.
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
순환기질환 - 혈관, 림프관 -.
Source: International Chair on Cardiometabolic Risk Metabolic Syndrome and Adipose Tissue Yuji Matsuzawa, MD, PhD Director.
Atherosclerosis. Atheroma are not merely filled with lipid, but contain cells whose functions critically influence atherogenesis: Intrinsic Vascular Wall.
Lipoprotein Structure, Function, and Metabolism
Is atherosclerosis a metabolic disease?
The Power of New Biomarkers to Detect Early Ischemia
Figure 2 Coronary vessels in atherosclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Coronary disease million Cancer Cerebrovascular disease
Figure 1 Radiation-induced effects on tumour cells
Lymphocyte migration.
S. S. Pullamsetti, R. Savai, W. Janssen, B. K. Dahal, W. Seeger, F
Advanced Nutrition Diet and Cardiovascular Disease 1
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Innate immune responses in atherosclerosis
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Cardiol. doi: /nrcardio
Volume 7, Issue 5, Pages (May 2008)
Figure 4 Macrophages in liver inflammation
Interaction of hypercholesterolemia and inflammation in atherogenesis
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 LDL autoimmunity in atherosclerosis
Arterial wall: structure and function
Figure 4 TNFSF inflammatory activities in tissue cells
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Inflammatory and immune cells involved in chronic obstructive pulmonary disease (COPD). Inflammatory and immune cells involved in chronic obstructive pulmonary.
Figure 3 Biologics that attenuate effector responses in the kidney
Pro-endometriotic niche in endometriosis
Diabetes and atherosclerosis
Inflammatory health effects of indoor and outdoor particulate matter
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions  Batya B. Davidovici, Naveed Sattar,
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Adaptive immunity in atherosclerosis
Lipid core constitution Activated macrophages accumulate lipids
Volume 7, Issue 5, Pages (May 2008)
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 GM-CSF — a key player in inflammation and autoimmunity
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Nat. Rev. Nephrol. doi: /nrneph
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Monocyte-Macrophages and T Cells in Atherosclerosis
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
Figure 3 Underlying mechanisms of TREG cells in atherosclerosis
Figure 2 Protective functions of HDL
Atherosclerosis Dr:HAMED ALGHAMDI.
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Mechanisms of virus-induced airway inflammation in chronic obstructive pulmonary disease (COPD). Mechanisms of virus-induced airway inflammation in chronic.
The Biological Role of Inflammation in Atherosclerosis
Macrophages in the Pathogenesis of Atherosclerosis
Figure 1 Monocyte and macrophage ontogeny
Nat. Rev. Rheumatol. doi: /nrrheum
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
NF-κB, Inflammation, and Metabolic Disease
Presentation transcript:

Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.185 Figure 2 Biological processes central to the pathogenesis of atherosclerosis Figure 2 | Biological processes central to the pathogenesis of atherosclerosis. Endothelial cells, lymphocytes, smooth muscle cells, monocytes, and macrophages are all involved in the pathogenesis of atherosclerosis from earliest foam cell formation through to development of advanced plaques. Initial activation of the endothelium from disruptions to normal shear stress results in and facilitates deposition of lipid in the subendothelial space. Endothelial activation also promotes recruitment of circulating monocytes where they terminally differentiate into macrophages, or differentiate and locally proliferate into distinct functional phenotypes. Activated macrophages take up lipid, which results in their transformation into macrophage-derived foam cells. As the foam cell population grows within lesions in the arterial wall, the rate of accumulation exceeds the rate of clearance, and eventually the foam cells coalesce into a lipid-rich necrotic core. ApoB, apolipoprotein B; CCR, C-C chemokine receptor; CRP, C-reactive protein; CX3CR1, CX3C chemokine receptor 1; ICAM1, intercellular adhesion molecule 1; MMP, matrix metalloproteinase; NLRP3, NACHT, LRR and PYD domains-containing protein 3; SAA, serum amyloid A; TNF, tumour necrosis factor; VCAM1, vascular cell adhesion protein 1. Ruparelia, N. et al. (2016) Inflammatory processes in cardiovascular disease: a route to targeted therapies Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.185